Idaho Technology, Applied Biosystems in Cross-licensing Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Idaho Technology and Life Technologies' Applied Biosystems business have entered into a cross-licensing pact covering instrument, software, and reagents, Idaho Technology said today.

The licensing deal includes patents that relate to real-time polymerase chain reaction methods and instrumentation, including the 5' nuclease process SYBR Green I in PCR reactions. More specific details and financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.